Psychopharmacology of adolescents with substance use disorders: Using diagnostic-specific treatments

Adolescent Substance Abuse: Research and Clinical Advances

Volumn , Issue , 2006, Pages 241-263

  Bukstein, Oscar G ^a   Cornelius, Jack ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34548139984     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511543968.014     Document Type: Chapter

References (113)

1. American Psychiatric Association (1995). Practice guidelines for the treatment of patients with substance use disorders: alcohol, cocaine, opioids. American J Psychiatry, 152(Suppl.), 1-59.
2. Anglin, M. D., Hser, Y. I., & Grella, C. E. (1997). Drug addiction and treatment careers among clients in the drug abuse treatment outcome study. Psychology of Addictive Behaviors, 11, 308-323.
3. Barkley, R. A., Fischer, M., Edelbrock, C. S., & Smallish, L. (1990). The adolescent outcome of hyperactive children diagnosed by research criteria, I: An 8-year prospective follow-up study. Journal of the American Academy of Child and Adolescent Psychiatry, 29, 546-557.
4. Barkley, R. A., Fischer, M., Smallish, L., & Fletcher, K. (2003). Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study. Pediatrics, 11, 97-109.
5. Bennett, M. E. & McCrady, B. S. (1993). Subtype by comorbidity in young adult substance abusers. Journal of Substance Abuse Treatment, 5, 365-378.
6. Biederman, J., Wilens, T., Mick, E., Spencer, T., & Farone, S. V. (1999). Pharmacotherapy of attention-deficit hyperactivity disorder reduces risk for substance use disorder. Pediatrics, 104, e20.
7. Brady, J. V. & Lucas, S.E. (1984). Testing Drugs for Physical Dependence Potential and Abuse Liability. [NIDA Research Monograph Series, No. 52.] Rockville, MD: National Institute on Drug Abuse.
8. Brady, K. T., Sonne, S. C., Malcom, R., etal. (2002). Carbamazepine in the treatment of cocaine dependence: subtyping by affective disorder. Experimental and Clinical Pharmacology, 10, 276-285.
9. Brown, S. A., Myers, M. G., Mott, M.A., & Vik, P.W. (1994). Correlates of success following treatment for adolescent substance abuse. Applied and Preventive Psychology, 3, 61-73.
10. Bruno, F. (1989). Buspirone in the treatment of alcoholic patients. Psychopathology, 22, 49-59.
11. Bukstein, O. G. (1994). Substance abuse. In M. Herson, R. T. Ammerman, & L. A. Sisson (eds.), Handbook of Aggressive and Destructive Behavior in Psychiatric Patients (pp. 445-468). New York: Plenum Press.
12. Bukstein, O. G. (1995). Adolescent Substance Abuse: Assessment, Prevention and Treatment. New York: John Wiley.
13. Bukstein, O. G. & Kithas, J. (2002). Adolescent substance use disorders. In D. Rosenberg, P.A. Davanzo, & S. Gershon (eds.), Child and Adolescent Psychopharmacology (pp. 346-373). New York: Maecel-Dekker.
14. Bukstein, O. G. & Tarter, R. E. (1998). Substance use disorders in children and adolescents. In Coffey (ed.), Textbook of Pediatric Neuropsychiatry (pp. 595-616). New York: American Psychiatric Press.
15. Bukstein O. G., Brent D. A., & Kaminer, Y. (1989). Comorbidity of substance abuse and other psychiatric disorders in adolescents. American Journal of Psychiatry, 146, 1131-1141.
16. Bukstein O., Glancy, L. J., & Kaminer, Y. (1992). Patterns of affective comorbidity in a clinical population of dually diagnosed substance abusers. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 1041-1045.
17. Castaneda, R., Levy, R., Hardy, M., & Trujillo, M. (2000). Long-acting stimulants for the treatment of attention-deficit disorder in cocaine-dependent adults. Psychiatric Services, 169-171.
18. Claassen, C. A. & Adinoff, B. (1999). Alcohol withdrawal syndrome: guidelines for management. CNS Drugs, 12, 279-291.
19. Clark, D.B., Bukstein, O.G., Smith, M.G., et al. (1995). Identifying anxiety disorders in adolescents hospitalized for alcohol abuse or dependence. Psychiatric Services, 46, 618-620.
20. Colby, S. M., Monti, P., Barnett, N., et al. (1998). Brief motivational interviewing in a hospital setting for adolescent smoking: a preliminary study. Journal of Consulting and Clinical Psychology, 66, 574-578.
21. Cornelius, J. R., Salloum, I. M., Ehler, J. G., et al. (1997). A double-blind, placebo-controlled study of fluoxetine in depressed alcoholics. Archives of General Psychiatry, 54, 700-705.
22. Cornelius, J. R., Bukstein, O. G., Birmaher, B., et al. (2000). Fluoxetine in adolescents with major depression and an alcohol use disorder: an open label trial. Addictive Behaviors, 25, 1-6.
23. Cornelius, J.R., Maisto, S.A., Martin, C.S., et al. (2004). Major depression associated with earlier alcohol relapse in treated teens with AUD. Addictive Behaviors, 29, 1035-1038.
24. Crowley, T. J. & Riggs, P.D. (1995). Adolescent substance use disorder with conduct disorder and comorbid conditions. In E. Rahdert & D. Czechowicz (eds.), Adolescent Drug Abuse: Clinical Assessment and Therapeutic Interventions (pp. 49-111). Rockville, MD: National Institute on Drug Abuse.
25. Crowley, T. J., Macdonald, M. J., Whitmore, E. A., & Mikulick, S. K. (1998a). Cannabis dependence, withdrawal and reinforcing effects among adolescents with conduct symptoms and substance use disorders. Drug and Alcohol Dependence, 50, 27-37.
26. Crowley, T. J., Mikulich, S. K., MacDonald, M.J., Young, S. E., & Zerbe, G. O. (1998b). Substance-dependent, conduct-disordered adolescent males: severity of diagnosis predicts 2-year outcome. Drug and Alcohol Dependence, 49, 225-237.
27. Crumley, F. E. (1990). Substance abuse and adolescent suicidal behavior. Journal of the American Medical Association, 263, 3051-3056.
28. Davidson, J.T. & Connor, K.M. (1998). Bupropion sustained release: a therapeutic overview. Journal of Clinical Psychiatry, 58(Suppl. 4), 25-31.
29. DEA Drug Enforcement Administration (1995). Methylphenidate Review Document. Washington, DC: DEA Office of Diversion Control, Drug and Chemical Evaluation Section.
30. Deas, D., Randall, C. L., Roberts, J. S., & Anton, R. F. (2000). A double-blind, placebocontrolled trial of sertraline in depressed adolescent alcoholics: a pilot study. Human Psychopharmacology, 15, 461-469.
31. Deas, D., Roberts, J.S., Randall, C. L., & Anton, R. F. (2002). Confirmatory analysis of the Adolescent Obsessive Compulsive Drinking Scale (A-OCDS): a measure of‘craving’ and problem drinking in adolescents/young adults. Journal of the National Medical Association, 94, 879-887.
32. Deykin, E. Y., Buka, S. L., & Zeena, T. H. (1992). Depressive illness among chemically dependent adolescents. American Journal of Psychiatry, 149, 1341-1347.
33. Estroff, T. W., Schwartz, R. H., & Hoffmann, N. G. (1989). Adolescent cocaine abuse: addictive potential, behavioral and psychiatric effects. Clinical Pediatrics, 28, 550-555.
34. Ferris, R. M., Cooper, B.R., & Maxwell, R. A. (1983). Studies of bupropion’s mechanism of antidepressant activity. Journal of Clinical Psychiatry, 44, 74-78.
35. Gardner, E. L. (1992). Brain reward mechanisms. In J. H. Lowinson, P. Ruiz, & R. B. Millman (eds.), Substance Abuse: A Comprehensive Text book (pp. 70-99). Baltimore, MD: Williams & Williams.
36. Geller, B., Cooper, T. B., Sun, K., et al. (1998). Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 171-178.
37. Goldstein, M. G. (1998). Bupropion sustained release and smoking cessation. Journal of Clinical Psychiatry, 59, 66-72.
38. Grella, C. E., Hser, Y., Joshi, V., & Rounds-Bryant, J. (2001). Drug treatment outcomes for adolescents with comorbid mental and substance use disorders. Journal of Nervous and Mental Disorders, 9, 384-392.
39. Griffith, J.D., Carranza, J., Griffith, C., & Miller, L. I. (1983). Bupropion: clinical assay for amphetamine-like potential. Journal of Clinical Psychiatry, 44, 206-208.
40. Haney, M., Ward, A. S., Comer, S. D., Hart, C. L., Foltin, R. W., & Fischman, M. W. Bupropion SR worsens mood during marijuana withdrawal in humans. Psychopharmacology, 155, 171-179
41. Hser, Y., Joshi, V., Anglin, M.D., & Fletcher, B. (1999). Predicting post-treatment cocaine abstinence for first-time admissions and treatment repeaters. American Journal of Public Health, 89, 666-671.
42. Hughes, J. R. (2000). New treatments of smoking cessation. CA: A Cancer Journal for Clinicians, 50, 143-151.
43. Hughes, J.R., Goldstein, M. C., Hurt, R. D., & Shiffman, S. (1999). Recent advances in the pharmcotherapy of smoking. Journal of the American Medical Association, 281, 72-76.
44. Huizinga, D. & Elliot, D.S. (1981). A Longitudinal Study of Drug Use and Delinquency in a National Sample of Youth: An Assessment of Causal Order. [Project Report No. 16, A National Youth Study.] Boulder, CO: Behavioral Research Institute.
45. Hurt, R. D., Sachs, P.P.L., Glover, E. D., et al. (1997). A comparison of sustained-release bupropion and placebo for smoking cessation. New England Journal of Medicine, 337, 1195-1202.
46. Jaffe, J. (1990). Drug addiction and drug abuse. In G. A. Goodman (ed.), The Pharmacological Basis of Therapeutics (pp. 522-573). New York: MacMillan.
47. Jaffe, S.L. (1991). Intranasal abuse of prescribed methylphenidate by an alcohol and drug abusing adolescent with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 773-775.
48. Kaminer, Y. (1994). Cocaine craving. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 592.
49. Karam-Hage, M. & Bower, K. (2000). Gabapentin treatment for insomnia associated with alcohol dependence. American Journal of Psychiatry, 157, 151.
50. Kennedy, B. P. & Minami, M. (1993). The Beech Hill Hospital/outward bound adolescent chemical dependency treatment program. Journal of Substance Abuse Treatment, 10, 395-406.
51. Klorman, R., Coons H. W., & Borgstadt, A. D. (1987). Effects of methylphenidate on adolescents with a childhood history of attention-deficit disorder. I: Clinical findings. Journal of the American Academy of Child and Adolescent Psychiatry, 26, 363-367.
52. Kollins, S.H., Rush, C. R., Pazzaglia, P. J., & Ali, J.A. (1998). Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate. Experimental and Clinical Psychopharmacology, 6, 367-374.
53. Kranzler, H.R. & Meyer, R. E. (1989). An open trial of buspirone in alcoholics. Journal of Clinical Psychopharmacology, 9, 379-380.
54. Kranzler, H. R., Burleson, J.A., Del Boca, F. K., et al. (1994). Buspirone treatment of anxious alcoholics: a placebo-controlled trial. Archives of General Psychiatry, 51, 720-731.
55. Kranzler, H. R., Burleson, J. A., Korner, P., et al. (1995). Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. American Journal of Psychiatry, 152, 391-397.
56. Kutcher, S., Kachur, E., Marton, P., & Szalai, J. (1992). Substance abuse among adolescents with chronic mental illnesses: a pilot study of descriptive and differentiating features. Canadian Journal of Psychiatry, 37, 428-431.
57. Langer, D.H., Sweeney, K.P., Bartenbach, D.E., Davis, P.M., & Menander, K.B. (1986). Evidence of lack of abuse or dependence following pemoline treatment: results of a retrospective survey. Drug and Alcohol Dependence, 17, 213-227.
58. Levin, F. R., Evans, S. M., McDowell, D. M., & Kleber, H. D. (1998). Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study. Journal of Clinical Psychiatry, 59, 300-305.
59. Lewinsohn, P. M., Hops, H., Roberts, R. E., & Seeley, J. R. (1993). Adolescent psychopathology: I. Prevalence and incidence of depression and other DSM-III - R disorders in high school students. Journal of Abnormal Psychology, 102, 133-144.
60. Lewinsohn, P.M., Rohde, P., & Seeley, J.R. (1996). Alcohol consumption in high school adolescents: frequency of use and dimensional structure of associated problems. Addiction, 91, 375-390.
61. Lifrak, P.D., Alterman A.I., O’Brien, C.P., & Volpicelli, J.R. (1997). Naltrexone for alcoholic adolescents. American Journal of Psychiatry, 154, 439-440.
62. Ling, W., Huber, A., & Rawson, R. A. (2001). New trends in opiate pharmacotherapy. Drug and Alcohol Review, 20, 79-94.
63. Loeber, R. (1988). Natural histories of conduct problems, delinquency and associated substance use. In B.B. Lahey & A. E. Kazdin (eds.), Advances in Clinical Child Psychology (pp. 73-124). New York: Plenum Press.
64. Maisto, S. A., Pollock, N. K., Lynch, K. G., Martin, C. S., & Ammerman, R. (2001). Course of functioning in adolescents 1 year after alcohol and other drug treatment. Psychology of Addictive Behavior, 15, 68-76.
65. Malcolm, R., Anton, R. F., Randall, C. L., et al. (1992). A placebo-controlled trial of buspirone in anxious inpatient alcoholics. Alcoholism, Clinical and Experimental Research, 16, 1007-13.
66. Martin, C. S., Kaczynski, N. A., Maisto S. A., Bukstein O. G., & Moss, H. B. (1995). Patterns of alcohol abuse and dependence symptoms in adolescent drinkers. Journal of Studies in Alcohol, 56, 672-680.
67. Mason, B. J., Kocis, J. H., Ritvo, E. C., Cutler, R. B. (1996). A double blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression. Journal of the American Medical Association, 275, 761-767.
68. McGrath, P.J., Nunes, E. V., Stewart, J.W., et al. (1996). Imipramine treatment of alcoholics with primary depression: a placebo-controlled clinical trial. Archives of General Psychiatry, 232-240.
69. Milan, R., Halikas, J.A., Meller, J.E., & Morse, C. (1991). Psychopathology among substance abusing juvenile offenders. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 569-574.
70. Moolchan, E. T., Ernst, M., & Henningfield, J. E. (2000). A review of tobacco smoking in adolescents: treatment implications. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 682-693.
71. Mueller, T. I., Stout, R. L., Rudden, S., et al. (1997). A double-blind, placebo controlled pilot study of carbamazepine for the treatment of alcohol dependence. Alcoholism, Clinical and Experimental Research, 21, 86-92.
72. Myers, W. C., Donahue, J. E., & Goldstein, M. R. (1995). Disulfiram for alcohol use disorders in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 2-4.
73. Myrick, H., Brady, K. T., & Robert, R. (2001). New developments in the psychopharmacology of alcohol dependence. American Journal of Addictions, 10, 3-15.
74. NIDA (National Institute on Drug Abuse) Community Epidemiology Work Group (1995). Epidemiologic Trends in Drug Abuse. Washington, DC: National Institutes of Health.
75. NIDA (National Institute on Drug Abuse 2000). Buprenorphine update: Questions and Answers. Rockville, MD: National Institute on Drug Abuse. Retrieved from, http://www.nida.nih.gov/ bupupdate.html.
76. Niederhofer, H. & Staffen, W. (2003). Acamprosate and its efficacy in treating alcohol- dependent adolescents. European Child and Adolescent Psychiatry, 12, 144-148.
77. NIH (National Institute of Health 1998). Effective medical treatment of opiate addiction. Journal of the American Medical Association, 280, 1936-1943.
78. Nunes, E.V., Quitkin, F.M., Donovan, S.J., et al. (1998). Imipramine treatment of opiate dependant patients with depressive disorders: a placebo-controlled trial. Archives of General Psychiatry, 55, 153-160.
79. Pelham, W. E., Vodde-Hamilton, M., Murphy, D. A., Greenstein, J., & Vallano, G. (1991). The effects of methylphenidate on ADHD adolescents in recreational, peer group and classroom settings. Journal of Clinical and Child Psychology, 20, 293-300.
80. Pelham, W. E., Molina, B.S., Meichenbaum, D., Gnagy, E., & Greenhouse, J. (2003, May). Stimulant effects on long term outcomes in ADHD individuals. In Proceedings of the 43rd Annual New Clinical Drug Evaluation Unit Meeting, Boca Raton, FL [poster].
81. Petrakis, I., Carroll, K. M., Nich, C., Gordon, L., Kosten, T., & Rounsaville, B. (1998). Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts. Drug and Alcohol Dependence, 50, 221-226.
82. Pettinati, H. M., Volpicelli, J. R., Luck, G., et al. (2001). Double-blind clinical trial of sertraline treatment for alcohol dependence. Journal of Clinical Psychopharmacology, 21, 143-153.
83. Riggs, P. D. (1998). Clinical approach to treatment of ADHD in adolescents with substance use disorders and conduct disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 331-332.
84. Riggs, P. D. & Davies, R. D. (2002). A clinical approach to integrating treatment for adolescent depression and substance abuse. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1253-1255.
85. Riggs, P.D. & Whitmore, E. A. (1999). Substance use disorders and disruptive behavior disorders. In R. L. Hendren (ed.), Disruptive Behavior Disorders in Children and Adolescents. Review of Psychiatry Series (pp. 133-173). Washington, DC: American Psychiatric Press.
86. Riggs, P.D., Baker, S., Mikulich, S.K., Young, S.E., & Crowley, T.J. (1995). Depression in substance-dependent delinquents. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 764-771.
87. Riggs, P. D., Thompson, L. L., Mikulich, S. K., Whitmore, E. A., & Crowley, T. J. (1996). An open trial of pemoline in drug-dependent delinquents with attention-deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1018-1024.
88. Riggs, P.D., Mikovich, S.K., Coffman, L.M., & Crowley, T.J. (1997). Fluoexetine in drug- dependant delinquents with major depression: an open trial. Journal of Child and Adolescent Psychopharmacology, 7, 87-95.
89. Riggs, P.D., Mikulich, S.K., & Hall, S. (2001). Effects of pemoline on ADHD, antisocial behaviors, and substance use in adolescents with conduct disorder and substance use disorder. In Proceedings of the 63rd Annual Scientific Meeting of the College on Problems of Drug Dependence, Scottsdale, AZ.
90. Rojas, N., Killen, J., Haydel, K., & Robinson, T. (1998). Nicotine dependence among adolescent smokers. Archives of Pediatric Adolescent Medicine, 152, 151-156.
91. Roy, A. (1998). Placebo-controlled study of sertraline in depressed recently abstinent alcoholics. Biological Psychiatry, 44, 633-637.
92. Roy-Byrne, P.P., Pages, K.P., Russo, J.E., et al. (2000). Nefazodone treatment of major depression in alcohol-dependent patients: a double-blind, placebo-controlled trial. Journal of Clinical Psychopharmacology, 20, 129-136.
93. Safer, D. & Zito, J. M. (2002). Adolescent stimulant use. Canadian Medical Association Journal, 167, 15.
94. Salloum, I. M. & Thase, M. E. (2002). Impact of substance abuse on the course and treatment of bipolar disorder. Bipolar Disorders, 2, 269-280.
95. Salloum, I. M., Cornelius, J. R., Daley, D. C., et al. (2005). Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism. Archives of General Psychiatry, 62, 37-45.
96. Schmitz, J. M., Averill, P., Stotts, A. L., etal. (2001). Fluoxetine treatment of cocaine-dependent patients with major depressive disorder. Drug and Alcohol Dependence, 63, 207-214.
97. Schubiner, H., Tzelepis, A., Isaacson, J.H., & Warbasse, L. H. (1995). The dual diagnosis of attention-deficit/hyperactivity disorder and substance abuse: case reports and literature review. Journal of Clinical Psychiatry, 56, 146-150.
98. Schubiner, H., Downer, K. K., Arfken, C. L., et al. (2002). Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Experimental and Clinical Psychopharmacology, 10, 286-294.
99. Smith, B.H., Pelham, W. E., Gnagy, E., & Yudell, R. S. (1998). Equivalent effects of stimulant treatment for attention-deficit hyperactivity disorder during childhood and adolescence. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 314-321.
100. Smith, T. A., House, R. F., & Croghan, I. T. (1996). Nicotine patch therapy in adolescent smokers. Pediatrics, 98, 659-667.
101. Solhkhah, R. & Wilens, T. E. (1998). Pharmacotherapy of adolescent AOD use disorders. Alcohol Health and Research World, 22, 122-126.
102. Spencer, T., Biederman, J., Wilens, T., et al. (1996). Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. Journal of the American Academy of Child and Adolescent Psychiatry, 24, 325-347.
103. Swift, R. M. (1999). Drug therapy: drug therapy for alcohol dependence. New England Journal of Medicine, 340, 1482-1490.
104. Tollefson, G. D., Montague-Clouse, J., & Tollefson, S.L. (1992). Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone). Journal of Clinical Psychopharmacology, 22, 19-26.
105. Turnquist, K., Frances, R., Rosenfeld, W., & Mobarak, A. (1983). Pemoline in attention deficit disorder and alcoholism: a case study. American Journal of Psychiatry, 140, 622-624.
106. van Hasselt, V.B., Ammerman, R.T., Glancy, L. J., & Buksein, O.G. (1992). Maltreatment in psychiatrically hospitalized dually diagnosed adolescent substance abusers. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 868-874.
107. Vingilis, E. & Smart, R. G. (1981). Physical dependence on alcohol in youth. In Y. Israel, B. Gleser, & H. Kalant (eds.), Research Advances in Alcohol and Drug Problems (pp. 197-215). New York: Plenum Press.
108. Volkow, N. D., Ding, Y., Fowler, J. S., et al. (1995). Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Archives of General Psychiatry, 456-463.
109. Wilens, T. E., Biederman, J., Spencer, T. J., & Frances, R. J. (1994). Comorbidity of attention- deficit disorder and psychoactive substance use disorders. Hospital and Community Psychiatry, 45, 421-435.
110. Wilens, T. E., Biederman, J., Abrantes, A. M., & Spencer, T. J. (1997). Clinical characteristics of psychiatrically referred adolescent outpatients with substance use disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 941-947.
111. Wilens, T. E., Spencer, T. J., Biederman, J., et al. (2001). A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. American Journal of Psychiatry, 158, 282-288.
112. Wise, R. A. & Rompre, P. P. (1989). Brain dopamine and reward. Annual Review of Psychology, 40, 191-225.
113. Wold, M. & Kaminer, Y. (1997). Naltrexone for alcohol abuse. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 6-7.